Zobrazeno 1 - 10
of 158
pro vyhledávání: '"L, Settas"'
Autor:
Clio P. Mavragani, D. Dimopoulou, Katerina Laskari, Theodoros Dimitroulas, E. Tsiakou, I. Kallitsakis, D. Pikazis, C. Gerodimos, Paraskevi V. Voulgari, Charalampos Papagoras, Panagiotis Athanassiou, A. Georgiadis, G. Gkoni, Maria G Tektonidou, D. Soukera, Dimitrios Vassilopoulos, Nikolaos Kougkas, E. Theodorou, C. Salamaliki, T. Sarikoudis, P. G. Vlachoyiannopoulos, J. Raftakis, Eleftheria P. Grika, G. Vosvotekas, P.P. Sfikakis, Christina G. Katsiari, L. Settas, P. Tsatsani, M. Zakalka, D. Daoussis, C. Iliou
Publikováno v:
Seminars in Arthritis and Rheumatism. 51:137-143
Objective To assess the efficacy and safety of the IL-1b inhibitor canakinumab in all adults with refractory Still's disease identified from the National Organization For Medicines for off-label drug use. Methods : In a retrospective longitudinal mul
Autor:
S. Kapoulas, L. Settas, S. Liakos, G. Karkavelas, M. Ageloudi, V. Kaloutsi, D. Grekas, E. Giannoulis
Publikováno v:
European Journal of Inflammation, Vol 3 (2005)
Reports on the association of multiple myeloma with systemic vasculitis are rare and concern, vasculitis due to crystalglobulin deposition in vessels or to polyarteritis nodosa PAN-like type necrotizing vasculitis. The association of multiple myeloma
Externí odkaz:
https://doaj.org/article/ac1be9aa510142b18ced654721b6910b
Autor:
D. Dimopoulou, S.-N. Liossis, I. Kallitsakis, Theodoros Dimitroulas, P.G. Vlachoyiannopoulos, Charalampos Papagoras, Panagiotis Athanassiou, A. Georgiadis, Maria G Tektonidou, T. Sarikoudis, D. Soukera, P. Tsatsani, P.P. Sfikakis, C. Gerodimos, Prodromos Sidiropoulos, E. Theodorou, E. Tsiakou, D. Karamitsos, G. Gkoni, Dimitrios Pikazis, G. Vosvotekas, Dimitrios Vassilopoulos, Clio P. Mavragani, M. Zakalka, Christina G. Katsiari, L. Settas, I. Raftakis, D. Daoussis, C. Iliou, Katerina Laskari, Paraskevi V. Voulgari
Publikováno v:
Annals of the Rheumatic Diseases. 79:845.1-845
Background:Interleukin-1 (IL-1) is a major mediator of the inflammatory cascade in Still’s disease and an established therapeutic target.Objectives:To assess the efficacy and safety of the IL-1b inhibitor canakinumab in adolescent and adult patient
Autor:
E. Petrikkou, A. Georgiadis, D. Psaltis, Dimitrios Vassilopoulos, E. Koukli, A. Bounas, P. Sidiropoulos, L. Settas, E. Kalogiannaki, I. Haratsis
Publikováno v:
Value in Health. 22:S432-S433
Autor:
L. Settas, George Giannakoulas, Haralambos Karvounis, Alexandros Garyfallos, Theodoros Dimitroulas, George D. Kitas
Publikováno v:
Scopus-Elsevier
Cardiac involvement in systemic sclerosis (SSc) is a frequent visceral complication that considerably affects the prognosis of the disease. The pathophysiologic hallmark is myocardial fibrosis which can progress leading to arrhythmia, right and/or le
Autor:
K. Yildirim, H. Uzkeser, A. Uyanik, S. Karatay, A. Kiziltunc, M. Keles, M. D. Kaya, C. O. Serdal, S. Emire, K. Fatih, Y. Ayla, T. Hasan, Y. Hasan, M. Radic, J. Radic, D. M. Kaliterna, S. Ugurlu, A. Engin, G. Ozgon, G. Hatemi, E. Akyayla, M. Bakir, H. Ozdogan, Y. Ozguler, S. Masatlioglu, S. Celik, H. Kilic, M. Cengiz, V. Hamuryudan, Y. Ozyazgan, E. Seyahi, S. Yurdakul, H. Yazici, C. Mat, K. Tascilar, Y. Demirel, S. Calli, S. Yildirim, M. Batumlu, D. Cevirgen, O. Alpaslan, M. Balli, F. Sametoglu, D. Doganyilmaz, T. F. Cermik, M. O. Erdede, B. Y. Yesilada, M. Yilmaz, M. Saglam, B. Pinar, T. Figen, K. Seher, O. Muyesser, G. Emel, E. Meral, A. Karakuzu, M. H. Uyanik, M. Atasoy, F. Gundogdu, B. Aktan, F. Alper, A. M. Kantarci, X. Agrogianni, I. Lintzeris, A. Lintzeri, K. Nas, Z. Demircan, M. Karakoc, U. Yuksel, R. Cevik, T. T. Sumer, I. Zagar, N. Gaspersic, H. Rafa, O. Medjeber, M. Belkhelfa, D. Hakem, C. Touil-Boukoffa, E. Aydogdu, S. Donmez, G. E. Pamuk, O. N. Pamuk, N. Cakir, N. S. Shahril, E. Mageswaren, L. M. Isa, S. Rajalingam, F. Abdullah, M. R. Kaslan, A. T. Samsudin, A. Arbi, H. Hussein, M. Brandao, A. R. Caldas, A. Marinho, A. M. da Silva, F. Farinha, C. Vasconcelos, C.-B. Choi, S.-R. Park, K. Wha Lee, S.-C. Bae, S. Beg, J. Popovich, S. Sessoms, T. Dimitroulas, G. Giannakoulas, K. Papadopoulou, H. Karvounis, H. Dimitroula, G. Koliakos, T. Karamitsos, D. Parcharidou, L. Settas, A. C. Nandagudi, S. Ziaj, G. M. Dabrera, T. Kim, K. Kim, C. Kang
Publikováno v:
Rheumatology. 50:ii14-ii21
Autor:
Anastasios N. Lasaridis, Georgia Karagiannopoulou, H. Dimitroula, L. Settas, Pantelis Sarafidis, Theodoros Dimitroulas, Stergios Kapoulas, Vasiliki Roma
Publikováno v:
Inflammation & Allergy - Drug Targets. 9:313-318
Systemic Sclerosis (SSc) is a multisystem connective tissue disease characterized by fibrosis of the skin and internal organs and extensive vasculopathy. We report a case of a 41 year-old white woman with a 10 year-history of limited scleroderma, who
Autor:
K. Krueger, Ernest Choy, P.L.C.M. van Riel, F. Navarro, B. Combe, L. Settas, Winfried Graninger, Mikkel Østergaard, R. van Vollenhoven, Paul Emery, Marco Matucci-Cerinic, Serge Steinfeld
Publikováno v:
Annals of the Rheumatic Diseases. 68:456-459
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease. In the majority of patients the course is progressive and leads to destruction of joints, functional disability, reduced quality of life and increased morbidity and mortality. Ad
Autor:
Georgios Karkavelas, E Giannoulis, L. Settas, M. Ageloudi, Dimitrios Grekas, S Liakos, V. Kaloutsi, Stergios Kapoulas
Publikováno v:
European Journal of Inflammation, Vol 3 (2005)
Reports on the association of multiple myeloma with systemic vasculitis are rare and concern, vasculitis due to crystalglobulin deposition in vessels or to polyarteritis nodosa PAN-like type necrotizing vasculitis. The association of multiple myeloma
Autor:
Vicente Rodriguez-Valverde, Saeed Fatenejad, L. Settas, Ronald Pedersen, Robert Landewé, Désirée van der Heijde, Lars Klareskog
Publikováno v:
Arthritis & Rheumatism. 52:49-60
Objective To evaluate different methods of presentation and analysis of radiographic data in a rheumatoid arthritis (RA) randomized controlled trial. Methods A double-blind randomized controlled trial including 682 patients with active RA who were tr